Global Diphtheria, Pertussis, and Tetanus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Diphtheria, Pertussis, and Tetanus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Diphtheria, Pertussis, and Tetanus Vaccine market size is estimated to be worth US$ 2595 million in 2021 and is forecast to a readjusted size of USD 3344.2 million by 2028 with a CAGR of 3.7% during review period. Hospitals accounting for % of the Diphtheria, Pertussis, and Tetanus Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DTaP segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine include Johnson & Johnson, GlaxoSmithKline, Sanofi, Lanzhou Institute of Biological, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Diphtheria, Pertussis, and Tetanus Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DTaP
Td
Tdap
Market segment by Application can be divided into
Hospitals
Clinics
Vaccination Centers
The key market players for global Diphtheria, Pertussis, and Tetanus Vaccine market are listed below:
Johnson & Johnson
GlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diphtheria, Pertussis, and Tetanus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine, with price, sales, revenue and global market share of Diphtheria, Pertussis, and Tetanus Vaccine from 2019 to 2022.
Chapter 3, the Diphtheria, Pertussis, and Tetanus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diphtheria, Pertussis, and Tetanus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Diphtheria, Pertussis, and Tetanus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diphtheria, Pertussis, and Tetanus Vaccine.
Chapter 13, 14, and 15, to describe Diphtheria, Pertussis, and Tetanus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market Analysis by Application
1.3.1 Overview: Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Vaccination Centers
1.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size & Forecast
1.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price (2017-2028)
1.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity Analysis
1.5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
1.6.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
1.6.3 Diphtheria, Pertussis, and Tetanus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lanzhou Institute of Biological
2.4.1 Lanzhou Institute of Biological Details
2.4.2 Lanzhou Institute of Biological Major Business
2.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Emergent
2.8.1 Emergent Details
2.8.2 Emergent Major Business
2.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business
2.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
2.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Diphtheria, Pertussis, and Tetanus Vaccine Breakdown Data by Manufacturer
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Diphtheria, Pertussis, and Tetanus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer Market Share in 2021
3.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Diphtheria, Pertussis, and Tetanus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Region
4.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2028)
4.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028)
4.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028)
4.5 South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
7.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
7.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
7.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
8.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
8.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
8.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Region
9.3.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
10.2 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
10.3 South America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
10.3.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
11.3.1 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Diphtheria, Pertussis, and Tetanus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Diphtheria, Pertussis, and Tetanus Vaccine
12.3 Diphtheria, Pertussis, and Tetanus Vaccine Production Process
12.4 Diphtheria, Pertussis, and Tetanus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Diphtheria, Pertussis, and Tetanus Vaccine Typical Distributors
13.3 Diphtheria, Pertussis, and Tetanus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 6. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 10. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 14. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lanzhou Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 16. Lanzhou Institute of Biological Major Business
Table 17. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 18. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 22. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 26. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Major Business
Table 29. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 30. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Emergent Basic Information, Manufacturing Base and Competitors
Table 32. Emergent Major Business
Table 33. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 34. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Astellas Basic Information, Manufacturing Base and Competitors
Table 36. Astellas Major Business
Table 37. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product and Services
Table 38. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 40. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Diphtheria, Pertussis, and Tetanus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Diphtheria, Pertussis, and Tetanus Vaccine Production Site of Key Manufacturer
Table 44. Diphtheria, Pertussis, and Tetanus Vaccine New Entrant and Capacity Expansion Plans
Table 45. Diphtheria, Pertussis, and Tetanus Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K MT)
Table 47. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K MT)
Table 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 51. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 52. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022) & (USD/MT)
Table 55. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2023-2028) & (USD/MT)
Table 56. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 57. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 58. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022) & (USD/MT)
Table 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2023-2028) & (USD/MT)
Table 62. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 63. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 64. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 67. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 68. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 69. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 70. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 71. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 72. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 75. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 76. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 77. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 78. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K MT)
Table 79. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K MT)
Table 80. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 83. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 84. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 85. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 86. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 87. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 88. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 91. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 92. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 93. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 94. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K MT)
Table 95. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K MT)
Table 96. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 99. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 100. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 101. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 102. Diphtheria, Pertussis, and Tetanus Vaccine Raw Material
Table 103. Key Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Diphtheria, Pertussis, and Tetanus Vaccine Typical Distributors
Table 107. Diphtheria, Pertussis, and Tetanus Vaccine Typical Customers
List of Figures
Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Picture
Figure 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type in 2021
Figure 3. DTaP
Figure 4. Td
Figure 5. Tdap
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application in 2021
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Vaccination Centers
Figure 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (2017-2028) & (K MT)
Figure 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (2017-2028) & (USD/MT)
Figure 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (2017-2028) & (K MT)
Figure 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
Figure 17. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
Figure 18. Diphtheria, Pertussis, and Tetanus Vaccine Market Trends
Figure 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturer in 2021
Figure 20. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 21. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2028)
Figure 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2028)
Figure 26. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 32. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 33. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2028) & (USD/MT)
Figure 34. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2028) & (USD/MT)
Figure 37. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 38. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 39. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country (2017-2028)
Figure 40. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country (2017-2028)
Figure 41. United States Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 45. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 46. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country (2017-2028)
Figure 47. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country (2017-2028)
Figure 48. Germany Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2028)
Figure 57. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 64. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 65. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country (2017-2028)
Figure 66. South America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Diphtheria, Pertussis, and Tetanus Vaccine in 2021
Figure 78. Manufacturing Process Analysis of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 79. Diphtheria, Pertussis, and Tetanus Vaccine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
